Raven Jaeger
Consejero General en CALCIMEDICA, INC. .
Perfil
Raven D.
Jaeger is currently the Chief Regulatory Officer at CalciMedica, Inc. Prior to this, she held the position of Director-Regulatory Affairs at Leadiant Biosciences, Inc. from 2011 to 2018.
In 2022, she served as the Chief Regulatory Officer at Diffusion Pharmaceuticals, Inc. Ms. Jaeger also worked as the Senior Vice President-Regulatory Affairs at BridgeBio Pharma, Inc. Ms. Jaeger completed her undergraduate degree at The Johns Hopkins University and her graduate degree at the University of Maryland.
Cargos activos de Raven Jaeger
| Empresas | Cargo | Inicio |
|---|---|---|
| CALCIMEDICA, INC. | Consejero General | 23/05/2023 |
Antiguos cargos conocidos de Raven Jaeger.
| Empresas | Cargo | Fin |
|---|---|---|
| DIFFUSION PHARMA | Consejero General | 01/03/2023 |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/04/2018 |
| BRIDGEBIO PHARMA, INC. | Consejero General | - |
Formación de Raven Jaeger.
| The Johns Hopkins University | Undergraduate Degree |
| University of Maryland | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRIDGEBIO PHARMA, INC. | Health Technology |
| CALCIMEDICA, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Diffusion Pharmaceuticals, Inc.
 Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. | Health Technology |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Raven Jaeger
